Skip to main content
Livermore
Livermore
ZHEN

CRCM LP

SEC CIK
0001483234
Latest filing
Aug 18, 2026

The latest 13F from CRCM LP covers Q2 2026 (filed Aug 18, 2026): 14 long positions worth $152.2M. The top 10 holdings make up 98.7% of the portfolio, and the largest is iShares Gold Trust (IAU) at 65.2%. Livermore has 13 filings on Form 13F from this institution, going back to Q1 2024.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
7
Est. +$33.8M
Added
4
Est. +$6.69M
Reduced
2
Est. −$793.2K
Sold out
1
Est. −$1.87M

Top 5 holdings

Share of this quarter's portfolio value

  1. IAUiShares Gold Trust
    65.2%$99.2MHistory
  2. IBITiShares Bitcoin Trust ETF
    6.6%$10.1MHistory
  3. RNAAtrium Therapeutics, Inc.
    5.7%$8.63MHistory
  4. AIFCAI Financial Corp
    4.9%$7.43MHistory
  5. PLBYPlayboy, Inc.
    4.6%$7.02MHistory

Share of portfolio

Top 5 holdings and the other 9 positions, by share of portfolio value

  1. IAU65.2%
  2. IBIT6.6%
  3. RNA5.7%
  4. AIFC4.9%
  5. PLBY4.6%
  6. Other 9 positions13.0%

Biggest buys

New and added positions, by estimated amount bought

  1. IBITiShares Bitcoin Trust ETF
    +$10.1MNewHistory
  2. RNAAtrium Therapeutics, Inc.
    +$8.63MNewHistory
  3. BTGOBitgo Holdings, Inc.
    +$6.80MNewHistory
  4. IAUiShares Gold Trust
    +$4.83MAddedHistory
  5. iShares Tr46436E718
    +$4.76MNew

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. IBITiShares Bitcoin Trust ETF
    +6.64 pp0.0% → 6.6%History
  2. RNAAtrium Therapeutics, Inc.
    +5.67 pp0.0% → 5.7%History
  3. BTGOBitgo Holdings, Inc.
    +4.47 pp0.0% → 4.5%History
  4. iShares Tr46436E718
    +3.13 pp0.0% → 3.1%
  5. VZLAVizsla Silver Corp.
    +1.84 pp0.0% → 1.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. STAAStaar Surgical Co
    −$1.87MSold outHistory
  2. BNRBurning Rock Biotech Ltd
    −$586.7KReducedHistory
  3. FRNMFreenome, Inc.
    −$206.5KReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. BNRBurning Rock Biotech Ltd
    −2.09 pp3.3% → 1.2%History
  2. STAAStaar Surgical Co
    −1.32 pp1.3% → 0.0%History
  3. FRNMFreenome, Inc.
    −0.21 pp0.9% → 0.7%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$152.2M
+$10.9M (+7.7%) vs. prior quarter
Positions
14
+6 vs. prior quarter
Top 10 concentration
98.7%
Top 10 as share of value
Turnover
1.8%
Q2 2026, one quarter
Average holding period
7.4 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2024), so positions held before then are understated.

13F filings by quarter

10 quarters, going back to Q1 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $345.7M (Q3 2025)

Q1 2024: $132.9MQ2 2024: $138.3MQ3 2024: $154.5MQ4 2024: $245.9MQ1 2025: $245.3MQ2 2025: $336.6MQ3 2025: $345.7MQ4 2025: $296.0MQ1 2026: $141.2MQ2 2026: $152.2M
Q1 2024Q2 2026
13F filings of CRCM LP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 18, 2026Amended14$152.2MIAUIBITRNAvs. Q1 2026SEC
Q1 2026May 13, 20268$141.2MIAUAIFCPLBYvs. Q4 2025SEC
Q4 2025Feb 13, 202611$296.0MGRALIAUHHHvs. Q3 2025SEC
Q3 2025Nov 14, 2025Amended10$345.7MIBITGRALHHHvs. Q2 2025SEC
Q2 2025Aug 13, 20259$336.6MGRALIBITHHHvs. Q1 2025SEC
Q1 2025May 14, 20256$245.3MIBITGRALPLBYvs. Q4 2024SEC
Q4 2024Feb 7, 20256$245.9MIBITGRALETHAvs. Q3 2024SEC
Q3 2024Nov 13, 20244$154.5MIBITGRALOMICvs. Q2 2024SEC
Q2 2024Aug 13, 20246$138.3MIBITIAUGRALvs. Q1 2024SEC
Q1 2024May 15, 20246$132.9MIBITIAUGrindr Inc.–SEC

13D and 13G filings

Companies where CRCM LP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

2 companies, largest stake first.

Companies where CRCM LP owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
AIFCAI Financial Corp13G/A10.00%12.7M shares+0.10 ppfrom 9.90%Oct 27, 20254 filingsAug 12, 2026SEC
GRALGRAIL, Inc.13G/A5.00%1.80M shares−0.11 ppfrom 5.11%Aug 30, 20245 filingsOct 6, 2025SEC

Latest filings

15 filings on file made by CRCM LP or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by CRCM LP
CompanyFiled (ET)FilerFormStakeChangeEvent dateFiling
AIFCAI Financial CorpAug 12, 202611:12 AM ETCRCM LPand 6 others13G/A10.00%12.7M shares+0.10 ppfrom 9.90%Jun 30, 2026SEC
FRNMFreenome, Inc.May 13, 20265:14 PM ETDing Chun Rand 3 others13G/A1.30%116.2K shares−6.70 ppfrom 8.00%Below 5%Mar 31, 2026SEC
BNRBurning Rock Biotech LtdMay 13, 20265:12 PM ETCRCM LPand 3 others13G/A3.20%282.1K shares−2.18 ppfrom 5.38%Below 5%Mar 31, 2026SEC
AIFCAI Financial CorpMay 13, 20265:09 PM ETCRCM LPand 5 others13G/A9.90%12.6M shares+1.20 ppfrom 8.70%Mar 31, 2026SEC
AIFCAI Financial CorpFeb 12, 20266:01 PM ETCRCM LPand 5 others13G/A8.70%10.9M shares+0.50 ppfrom 8.20%Dec 31, 2025SEC
FRNMFreenome, Inc.Jan 13, 20264:36 PM ETDing Chun Rand 3 others13G8.00%716.6K sharesNewJan 6, 2026SEC
BNRBurning Rock Biotech LtdDec 19, 20256:00 PM ETCRCM LPand 3 others13G5.38%486.4K sharesNewDec 16, 2025SEC
AIFCAI Financial CorpOct 27, 20254:10 PM ETCRCM LPand 5 others13G8.20%8.97M sharesNewOct 20, 2025SEC
GRALGRAIL, Inc.Oct 6, 20257:15 PM ETCRCM LPand 8 others13G/A5.00%1.80M shares−0.11 ppfrom 5.11%Oct 6, 2025SEC
GRALGRAIL, Inc.Oct 3, 20257:05 PM ETCRCM LPand 8 others13G/A5.11%1.84M shares–Sep 30, 2025SEC
OMICSingular Genomics Systems, Inc.Nov 22, 2024CRCM LP13D/AOld format–––SEC
OMICSingular Genomics Systems, Inc.Nov 5, 2024CRCM LP13DOld format–New–SEC
GRALGRAIL, Inc.Sep 30, 2024CRCM LP13G/AOld format–––SEC
GRALGRAIL, Inc.Sep 30, 2024CRCM LP13G/AOld format–––SEC
GRALGRAIL, Inc.Aug 30, 2024CRCM LP13GOld format–New–SEC